Skip to content

Advertisement

BMC Infectious Diseases

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda

  • Victor Ssempijja1, 9Email authorView ORCID ID profile,
  • Gertrude Nakigozi2,
  • Larry Chang2, 3, 4,
  • Ron Gray2, 4,
  • Maria Wawer2, 4,
  • Anthony Ndyanabo2,
  • Jingo Kasule2,
  • David Serwadda2, 5,
  • Barbara Castelnuovo6,
  • Anja van’t Hoog7 and
  • Steven James Reynolds2, 3, 4, 8
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:582

https://doi.org/10.1186/s12879-017-2680-6

Received: 23 April 2017

Accepted: 13 August 2017

Published: 22 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Apr 2017 Submitted Original manuscript
15 May 2017 Reviewed Reviewer Report - Yoann Madec
18 May 2017 Reviewed Reviewer Report - Habib Ramadhani
4 Jul 2017 Author responded Author comments - Victor Ssempijja
Resubmission - Version 2
4 Jul 2017 Submitted Manuscript version 2
10 Aug 2017 Author responded Author comments - Victor Ssempijja
Resubmission - Version 3
10 Aug 2017 Submitted Manuscript version 3
Publishing
13 Aug 2017 Editorially accepted
22 Aug 2017 Article published 10.1186/s12879-017-2680-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick, USA
(2)
Rakai Health Sciences Program, Kalisizo, Uganda
(3)
Johns Hopkins School of Medicine, Baltimore, USA
(4)
Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
(5)
School of Public Health, Makerere University College of Health Sciences, Kampala, Uganda
(6)
Infectious Disease Institute, Makerere University College of Health Sciences, Kampala, Uganda
(7)
Department of Global Health –Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
(8)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
(9)
Clinical Monitoring Research Program (CMRP), Leidos Biomedical Research, Inc., Frederick, USA

Advertisement